A Functional Magnetic Resonance Imaging Investigation of Transcranial

Status Completed

Clinical Trial Summary

This study evaluates the effect of frontal cortex transcranial direct current stimulation (tDCS) on the neural correlates of threat processing in healthy volunteers with a high level of trait anxiety. All participants received both active and sham tDCS and underwent a functional imaging scan whilst carrying out an attentional control task with fearful distractors.

Clinical Trial Description

There is a growing body of evidence suggesting that repeated administration of prefrontal transcranial direct current stimulation (tDCS) is a potential effective treatment for depression through restoring a left/right imbalance in frontal brain activity (Boggio et al., 2008; Loo et al., 2012) and improving top down control of anxiety responses.

An initial exploratory study was carried out in 2012 (Ironside et al 2015) to examine the effects of tDCS on emotional processing in healthy volunteers using a range of tasks and questionnaires. Using a dot probe task, which measures attention to happy or fearful faces, it was found that tDCS has the potential ability to reverse an attentional bias to fearful faces seen in the placebo group. This indicates that anxiety responses may be modified using tDCS and therefore this follow on study seeks to further explore the role of tDCS in trait anxiety and investigate the neural correlates of this with fMRI.

The present study uses behavioural and neuroimaging results to examine how tDCS affects emotional processing relevant to trait anxiety. A within-subjects design increases the power of the study, given limited resources to carry out extensive neuroimaging. Our working hypothesis is that tDCS may alter activity in cortical regions relevant to attentional control and anxiety.

The findings of this study will be used to determine parameters for future patient studies, involving participants with generalized anxiety disorder or major depression. The ultimate aim, explored through further studies, is to understand and improve how tDCS might be used in the treatment of these disorders. ;

Study Design

Related Conditions & MeSH terms

Anxiety State

Clinical Trial Details

NCT number	NCT03623815
Study type	Interventional
Source	University of Oxford
Contact
Status	Completed
Phase	N/A
Start date	February 5, 2015
Completion date	October 6, 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05760482` - Evaluation of the Relationship Between Bruxism and Tryptophan Metabolites	N/A
Recruiting	`NCT04368416` - Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints
Completed	`NCT01190774` - Anxiety Assessment Intervention in Dental Patients	Phase 2/Phase 3
Not yet recruiting	`NCT06418269` - The Effect of Therapeutic Play on Anxiety and Fear Levels in Children With Diabetes	N/A
Recruiting	`NCT06215456` - Virtual Reality to Reduce Periprocedural Anxiety During Invasive Coronary Angiography	N/A
Completed	`NCT06114524` - Effect of Binaural Beats on Level of Anxiety and Toleration in Patients Undergoing Upper Gastrointestinal Endoscopy Without Sedation	N/A
Completed	`NCT05316415` - The Effects of Music on the Anxiety and Sleep Quality of Pregnant Women on Bed Rest for a High-risk Pregnancy	N/A
Recruiting	`NCT05433636` - Mindful Waiting Room	N/A
Recruiting	`NCT06034496` - Cranial Electrotherapy Stimulation and Acute Stress	N/A
Recruiting	`NCT06187090` - The Supplementation Therapy in Autism and Response to Treatment Study	N/A
Completed	`NCT05499767` - HEPPI: Efficacy of a Cognitive-Emotional Intervention for Homebound Older Adults	N/A
Not yet recruiting	`NCT03671317` - Medical Clowns for Pediatric Blood Draw	N/A
Completed	`NCT04040036` - Effects of Virtual Reality on Pain, Fear and Anxiety During Blood Draw in Children Aged 5-12 Years Old	N/A
Terminated	`NCT03227562` - Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?	Phase 3
Completed	`NCT04568551` - COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor
Recruiting	`NCT06190184` - Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions	N/A
Completed	`NCT04601545` - The Virtual Reality Therapy as a Pulmonary Rehabilitation Supporting Method	N/A
Completed	`NCT06223412` - Visual Based Program and Climate Change	N/A
Recruiting	`NCT04356638` - a Phase III Trial of Safety and Efficacy of Premedication With Dexmedetomidine and Midazolam in Pediatric Patients	Phase 3
Completed	`NCT03977948` - Qualitative and Systemic Assessment of a Nurse Intervention an Inpatient Child and His or Her Parents

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Functional Magnetic Resonance Imaging Investigation of Transcranial Direct Current Stimulation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms